BAX - Baxter International Inc.
NEXT EARNINGS:
May 7, 2026
EPS Est: $0.35
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$19.75
DETAILS
HIGH:
$25.00
LOW:
$15.00
MEDIAN:
$19.50
CONSENSUS:
$19.75
DOWNSIDE:
4.27%
Market Cap:
10.61B
Volume:
5,357,758
Avg Volume:
9,045,015
52 Week Range:
17.4-37.74
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.58
Last Dividend:
$0.52
Exchange:
NYSE
Country:
US
Employees:
38,000
IPO Date:
1981-10-27
EPS (TTM):
-1.75
P/E Ratio:
-10.24
Revenue (TTM):
11.24B
Total Assets:
20.05B
Total Debt:
10.00B
Cash & Equiv:
1.97B
Rev Growth (5Y):
-0.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-22.6%
ROCE:
4.1%
Debt/Equity:
1.63
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $0.44 | $0.53 | -17.0% | $3.0B | $2.6B | +14.2% |
| 2025-10-30 | $0.69 | $0.60 | +15.0% | $2.8B | $2.8B | +0.4% |
| 2025-07-31 | $0.59 | $0.60 | -1.7% | $2.8B | $2.9B | -2.3% |
| 2025-05-01 | $0.55 | $0.48 | +13.8% | $2.6B | $2.6B | +1.4% |
| 2025-02-20 | $0.58 | $0.53 | +9.8% | $10.6B | $2.7B | +297.8% |
| 2024-11-08 | $0.80 | $0.78 | +2.6% | $2.7B | $3.8B | -29.8% |
| 2024-08-06 | $0.68 | $0.66 | +2.7% | $3.8B | $3.8B | +1.5% |
| 2024-05-02 | $0.65 | $0.61 | +7.1% | $3.6B | $3.6B | +1.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.24B | 10.64B | 10.36B | 10.06B | 12.15B | 11.67B | 11.36B | 11.10B | 10.58B | 10.16B | 9.97B | 10.72B |
| Net Income | (957.00M) | (649.00M) | 2.66B | (2.43B) | 1.28B | 1.10B | 1.00B | 1.55B | 602.00M | 4.96B | 968.00M | 2.50B |
| EPS | -1.75 | -1.27 | 5.25 | -4.83 | 2.56 | 2.17 | 1.97 | 3.04 | 1.11 | 9.09 | 1.78 | 4.61 |
| Total Assets | 20.05B | 25.78B | 28.28B | 28.29B | 33.52B | 20.02B | 18.19B | 15.72B | 17.11B | 15.55B | 20.96B | 26.14B |
| Total Debt | 10.00B | 13.45B | 14.11B | 17.20B | 18.31B | 6.80B | 5.96B | 3.48B | 3.51B | 2.78B | 6.51B | 9.03B |
| Cash & Equivalents | 1.97B | 1.76B | 3.08B | 1.72B | 2.95B | 3.73B | 3.33B | 1.84B | 3.39B | 2.80B | 2.21B | 2.92B |
| Operating Cash Flow | 845.00M | 1.02B | 1.73B | 1.21B | 2.22B | 1.87B | 2.10B | 2.02B | 1.71B | 1.65B | 1.77B | 3.21B |
| Free Cash Flow | 323.00M | 559.00M | 1.29B | 576.00M | 1.53B | 1.16B | 1.41B | 1.36B | 1.10B | 935.00M | 860.00M | 2.29B |
| FCF per Share | 0.63 | 1.10 | 2.55 | 1.14 | 3.05 | 2.28 | 2.77 | 2.54 | 2.02 | 1.71 | 1.58 | 4.23 |
| Book Value | 6.13B | 6.96B | 8.40B | 5.83B | 9.08B | 8.69B | 7.88B | 7.84B | 9.12B | 8.29B | 8.85B | 8.12B |
| Cash & ST Investments | 1.97B | 1.76B | 3.08B | 1.72B | 2.95B | 3.73B | 3.33B | 1.84B | 3.39B | 2.80B | 7.36B | 2.92B |
| ROC Equity | -0.16 | -0.09 | 0.32 | -0.42 | 0.14 | 0.13 | 0.13 | 0.20 | 0.07 | 0.60 | 0.11 | 0.31 |